Tumor bed boost radiotherapy in breast cancer: A review of current techniques

Saudi Medical Journal

Volumn 33, Issue 4, 2012, Pages 353-366

  Bahadur, Yasir A ^a   Constantinescu, Camelia T ^b  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLIP; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DISEASE FREE SURVIVAL; ELECTRON BEAM; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PEROPERATIVE ECHOGRAPHY; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TOMOTHERAPY;

BREAST NEOPLASMS; FEMALE; HUMANS;

EID: 84859709723     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty five years of follow-up of a randomized trial comparing Total Mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
2. Early Breast Cancer Trialists' Collaborative Group. Radiotherapy for early breast cancer. Cochrane Database Syst Rev 2002; 2: CD003647.
3. Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005; 366: 2087-2106.
4. Jalali R, Singh S, Budrukkar A. Techniques of tumour bed boost irradiation in breast-conserving therapy: Current evidence and suggested guidelines. Acta Oncologica 2007; 46: 879-892.
5. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van Den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378-1387.
6. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van Den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25: 3259-3265.
7. Vrieling C, Collette L, Forquet A, Hoogenraad WJ, Horiot JC, Jager JJ. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 1999; 45: 677-685.
8. Arriagada R, Le MG, Dunant A, Tubiana M, Contesso G. Twenty-five years of follow-up in patients with operable breast carcinoma. Correlation between clinicopathologic factors and the risk of death in each 5 year period. Cancer 2006; 106: 743-749.
9. Pass H, Vicini FA, Kestin LL, Decker D, Pettinga J. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 2004; 101: 713-720.
10. Fodor J, Mozsa E, Zaka Z, Polgar C, Major T. Local relapse in young (≤40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results. Magy Onkol 2005; 49: 205-208.
11. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Bogaert WV, Barillot I. Impact of radiation dose on local control, fibrosis and survival after breast-conserving treatment: 10 years results of the EORTC Trial 22881-10882. Procceding of the OncoLink at the San Antonio Breast Cancer Symposium; 2006; Pennsylvania, USA. Pennsylvania (USA): Abramson Cancer Center of the University of Pennsylvania; 2006.
12. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Eng J Med 2001; 345: 1378-1387.
13. Poortmans PM, Collette L, Horiot JC, Van den Bogaert WF, Fourquet A, Kuten A, et al. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol 2009; 90: 80-85.
14. Polgar C, Orosz Z, Fodor J, Major T, Mangel L, Takacsi-Nagy Z. The effect of tumour bed boost on local control after breastconserving surgery. First results of the randomized boost trial of the National Institute of Oncology. Magy Onkol 2001; 45: 385-391.
15. Polgar C, Fodor J, Major T, Orosz Z, Nemeth G. The role of boost irradiation in the conservative treatment of Stage I-II breast cancer. Pathol Oncol Res 2001; 7: 241-250.
16. Vass S, Bairati I. A cosmetic evaluation of breast cancer treatment: A randomized study of radiotherapy boost technique. Int J Radiat Oncol Biol Phys 2005; 62: 1274-1282.
17. Ma CM, Ding M, Li JS. A comparative dosimetric study on tangential photon beams intensity-modulated radiation therapy (IMRT) and modulated electron radiotherapy (MERT) for breast cancer treatment. Phys Med Biol 2003; 48: 909-924.
18. Polgar C, Major T, Fodor J, Nemeth G, Orosz Z, Sulyok Z. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breastconserving surgery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 2004; 60: 1173-1181.
19. Machtay M, Lanciano R, Hoffman J, Hanks GE. Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. Int J Radiat Oncol Biol Phys 1994; 30: 43-48.
20. Kovner F, Agay R, Merimsky O, Stadler J, Klausner J, Inbar M. Clips and scar as the guidelines for breast radiation boost after lumpectomy. Eur J Surg Oncol 1999; 25: 483-486.
21. Oh KS, Kong FM, Griffith KA, Yanke B, Pierce LJ. Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 2006; 66: 680-686.
22. Harrington KJ, Harrison M, Bayle P, Evans K, Dunn PA, Lambert HE. Surgical clips in planning the electron boost in breast cancer: A qualitative and quantitative evaluation. Int J Radiat Oncol Biol Phys 1996; 34: 579-584.
23. Weed DW, Yan D, Martinez AA, Vicini FA, Wilkinson TJ, Wong J. The validity of surgical clips as a radiographic surrogate for lumpectomy cavity in image guided Accelerated Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2004; 60: 484-492.
24. Rabinovitch R, Finlayson C, Pan Z, Lewin J, Humphires Z, Biffl W. Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: A prospective clinical study. Int J Radiat Oncol Biol Phys 2000; 47: 313-317.
25. Kirova YM, Castro Pena P, Hijal T, Fournier-Bidoz N, Laki F, Sigal-Zafrani B, et al. Improving the Definition of Tumor bed Boost with the Use of Surgical Clips and Image Registartion in Breast Cancer Patients. Int J Radiat Oncol Biol Phys 2010; 78: 1352-1355.
26. Yang Z, Chen J, Hu W, Pan Z, Cai G, Yu X, et al. Planning the breast boost: How accurately do surgical clips represent the CT seroma? Radiother Oncol 2010; 97: 530-534.
27. Goldberg H, Prosnitz RG, Olson JA, Marks LB. Definition of Postlumpectomy Tumor bed for Radiotherapy Boost Field Planning: CT versus Surgical Clips. Int J Radiat Oncol Biol Phys 2005; 63: 209-213.
28. Smitt MC, Birdwell RL, Goffinet DR. Breast electron boost planning: Comparison of CT and US. Radiology 2001; 219; 203-206.
29. Coles CE, Moody AM, Wilson CB, Burnet NG. Reduction of radiotherapy-induced late complications in early breast cancer: The role of intensity-modulated radiation therapy and partial breast irradiation. Clin Oncol 2005; 17: 98-110.
30. Wong P, Muanza T, Reynard E, Robert K, Barker J, Sultanem K. Use of 3-D Ultrasound in the Detection of Breast Tumor bed Displacement during Radiotherapy. Int J Radiat Oncol Biol Phys 2011; 79: 39-45.
31. Goldberg H, Prosnitz RG, Olson JA, Marks LB. Definition of postlumpectomy tumor bed for radiotherapy for radiotherapy boost field planning: CT versus surgical clips. Int J Radiat Oncol Biol Phys 2005; 63: 209-213.
32. Al Uwini S, Antonini N, Poortmans PM, Boersma L, Hurkmans C, Leer JW, et al. The influence of the use of CTplanning on the irradiated boost volume in breast-conserving treatment. Radiother Oncol 2009; 93: 87-93.
33. Kader HA, Truong PT, Pai R, Panades M, Jones S, Ansbacher W, et al. When is CT-based postoperative seroma most useful to plan partial breast radiotherapy? evaluation of clinical factors affecting seroma volume and clarity. Int J Radiat Oncol Biol Phys 2008; 72: 1064-1069.
34. Kokubo M, Mitsumori M, Yamamoto C, Fujishiro S, Mise K, Kodama H. Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy. Breast Cancer 2001; 8: 222-228.
35. Giezen M, Kouwenhoven E, Scholten AN, Coerkemp EG, Heijenbrok M, Jansen WP, et al. Magnetic Resonance Imaging versus Computed Tomography-Based Target Volume Delineation of the Glandular Breast Tissue (Clinical Target Volume Breast) in Breast-Conserving Therapy: An Exploratory Study. Int J Radiat Oncol Biol Phys 2010; 81: 804-811.
36. Lee G, Fyles A, Tran P, Cho J, Easson A, Fenkell L, et al. Magnetic Resonance Imaging Assessment for Clinical Target Volume Delineation of the Postoperative Cavity in Breast Radiotherapy. Int J Radiat Oncol Biol Phys 2009; 75: 30-35.
37. Whipp EC, Halliwell M. Magnetic Resonance Imaging Appearances in the Postoperative Breast: The Clinical Target Volume-Tumor and its Relationship to the Chest Wall. Int J Radiat Oncol Biol Phys 2008; 72: 49-57.
38. Hepel JT, Evans SB, Hiatt JR, Price L, Dipetrillo T, Wazer DE, et al. Planning the Breast Boost: Comparison of Three Techniques and Evolution of Tumor bed During Treatment. Int J Radiation Oncology Biol Phys 2009; 74: 458-463.
39. Haba Y, Britton P, Sinnatamby R, Sycamore CM, Wilson C. Can ultrasound improve the accuracy of delivery of electron boost treatment following breast-conserving surgery? Eur J Cancer 2001; 37: 38.
40. Leonard C, Harlow CL, Coffin C, Drose J, Norton L, Kinzie J. Use of ultrasound to guide radiation boost planning following lumpectomy for carcinoma of the breast. Int J Radiat Oncol Biol Phys 1993; 27: 1193-1197.
41. Kirk M, Dickler A, Mehta P, Khan A, Chu J, Griem K, et al. A Dosimetric Analysis Comparing an Electron Tumor bed Boost with a Tumor bed Boost Utilizing the MammoSite Breast Brachytherapy Applicator. Int J Radiat Oncol Biol Phys 2007; 69: 1305-1309.
42. Hill-Kayser CE, Chacko D, Hwang WT, Vapiwala N, Solin LJ. Long-Term Clinical and Cosmetic Outcomes after Breast Conservation Treatment for Women with Early-Stage Breast Carcinoma According to the Type of Breast Boost. Int J Radiat Oncol Biol Phys 2011: 79: 1048-1054.
43. Poortmans P, Bartelink H, Horiot JC, Struikmans H, Van den Bogaert W, Fourquet A, et al. The influence of the boost technique on local control in breast-conserving treatment in the EORTC 'boost versus no boost' randomised trial. Radiother Oncol 2004; 72: 25-33.
44. Bahadur Y, Constantinescu C, Fawzy E, Ghassal N. 3DCRT techniques for simultaneously integrated boost in breast-conserving radiation therapy. Medical Journal of Cairo University 2009; 77: 47-55.
45. Kirova YM, Founier-Bidoz N, Servois V, Laki F, Pollet GA, Salmon R, et al. How to Boost the Breast Tumor bed? A Multidisciplinary Approach in Eight Steps. Int J Radiat Oncol Biol Phys 2008; 72: 494-500.
46. International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements. ICRU Report 1999. (Update: 2010 August 23). Available from URL: http://en.wikibooks.org/wiki/Radiation_Oncology/ Physics/ICRU
47. Struikmans H, Wárlám-Rodenhuis C, Stam T, Stapper G, Tersteeg RJ, Bol GH, et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol 2005; 76: 293-299.
48. Topolnjak R, van Vliet-Vroegindeweij C, Sonke JJ, Minkema D, Remeijer P, Nijkamp J, et al. Breast-conserving therapy: radiotherapy margins for breast tumor bed boost. Int J Radiat Oncol Biol Phys 2008; 72: 941-948.
49. Hurkmans C, Admiraal M, van der Sangen M, Dijkmans I. Significance of breast boost volume changes during radiotherapy in relation to current clinical interobserver variations. Radiother Oncol 2009; 90: 60-65.
50. Krawczyk JJ, Engel B. The importance of surgical clips for adequate tangential beam planning in breast-conserving surgery and irradiation. Int J Radiat Oncol Biol Phys 1999; 43: 347-350.
51. White EA, Cho J, Vallis KA, Sharpe MB, Lee G, Blackburn H, et al. Cone beam computed tomography guidance for setup of patients receiving accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2007; 68: 547-554.
52. Weed DW, Yan D, Martinez AA, Vicini FA, Wilkinson TJ, Wong J. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2004; 60: 484-492.
53. Kim LH, Wong J, Yan D. On-line localization of the lumpectomy cavity using surgical clips. Int J Radiat Oncol Biol Phys 2007; 69: 1305-1309.
54. Bahadur YA, Constantinescu C, Hassouna AH. Significant interfraction variations during tangential breast irradiation: an indication for image-guided radiotherapy for simultaneously integrated boost. Saudi Med J 2011; 32: 241-248.
55. Horton JK, Halle JS, Chang SX and Sartor CI. Comparison of three concomitant boost techniques for early stage breast cancer. Int J Radiat Oncol Biol Phys 2006; 64: 168-175.
56. Van der Laan HP, Dolsma WV, Schilstra C, Korevaar EW, de Bock GH, Maduro JH, et al. Limited benefit of inversely optimised intensity modulation in breast-conserving radiotherapy with simultaneously integrated boost. Radiother Oncol 2010; 94: 3.
57. Conway L, Tsang Y. A forward-planning solution for the IMPORT HIGH Breast IMRT Trial (abstract). Clin Oncol 2007; 19: S15.
58. Formenti SC, Truong MT, Goldberg JD, Mukhi V, Rosenstein B, Roses D. Prone accelerated partial breast-conserving surgery: preliminary clinical results and dose volume histogram analysis. Int J Radiat Oncol Biol Phys 2004; 60: 493-504.
59. Letts N, Remouchamps V, Martinez A, Vicini F, Wong J. Set-up inaccuracies in breast irradiation: A comparison of free breathing and Active Breathing Control (ABC) treatment using Electronic Portal Images (EPI) (abstract). Int J Radiat Oncol Biol Phys 2003; 57: 309.
60. Sarrut D, Boldea V, Ayadi M, Badel JN, Ginestet C, Clippe S. Nonrigid registration method to assess reproducibility of breath-holding with ABC in lung cancer. Int J Radiat Oncol Biol Phys 2005; 61: 594-607.
61. Kinoshita R, Shimizu S, Taguchi H, Katoh N, Fujino M, Onomaru R, et al. Three-Dimensional Intrafractional Motion of Breast During Tangential Breast Irradiation Monitored with High-Sampling Frequency Using a Real-Time Tumor-Tracking Radiotherapy System. Int J Radiat Oncol Biol Phys 2008; 70: 931-934.
62. Korreman SS, Pedersen AN, Nøttrup TJ, Specht L, Nystrom H. Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique. Radiother Oncol 2005; 76: 311-318.
63. Jiang SB, Wolfgang J, Mageras GS. Quality Assurance Challenges for Motion-Adaptive Radiation Therapy: Gating, Breath Holding, and Four-Dimensional Computed Tomography. Int J Radiat Oncol Biol Phys 2008; 71: S103-S107.
64. Mitchell J, Formenti SC, Dewyngaert JK. Interfraction and Intrafraction Setup Variability for Prone Breast Radiation Therapy. Int J Radiat Oncol Biol Phys 2010; 76: 1571-1577.
65. Qi S, White J, Rabinowitch R, Merrell K, Sood A, Bauer A, et al. Respiratory Organ Motion and Dosimetric Impact on Breast and Nodal Irradiation. Int J Radiat Oncol Biol Phys 2010; 78: 609-617.
66. Morrow NV, Stepaniak C, White J, Wilson JF, Li XA. Intraand Interfractional Variations for Prone Breast Irradiation: An Indication for Image-Guided Radiotherapy. Int J Radiat Oncol Biol Phys 2007; 69: 910-917.
67. Kirby AM, Evans PM, Helyer SJ, Donovan EM, Convery HM, Yarnold JR. A randomised trial of Supine versus Prone breast radiotherapy (SuPr study): Comparing set-up errors and respiratory motion. Radiother Oncol 2011; 100: 221-226.
68. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 years survival: An overview of the randomised trials. Lancet 2005; 366: 2087-2106.
69. Hall EJ, Phil D. Intensity-Modulated Radiation Therapy, Protons, and the Risk of Second Cancers. Int J Radiat Oncol Biol Phys 2006; 65: 1-7.
70. Thilmanl C, Zabel A, Nill S, Rhein B, Hoess A and Haering P. Intensity-modulated radiotherapy of the female breast. Med Dosimetry 2002; 27: 79-90.
71. Peulen H, Hanbeukers B, Boersma L, Baardwijk A, van den Ende P, Houben R, et al. Forward Intensity-Modulated Radiotherapy Planning in Breast Cancer to Improve Dose Homogeneity: Feasibility of Class Solutions. Int J Radiat Oncol Biol Phys 2012; 82: 394-400.
72. Pili G, Grimaldi L, Fidanza C, Florio ET, Petruzzelli MF, D'Errico MP, et al. Geometric and Dosimetric Approach to Determine Probability of Late Cardiac Mortality in Left Tangential Breast Irradiation: Comparison between Wedged Beams and Field-in-Field Technique. Int J Radiat Oncol Biol Phys 2011; 81: 894-900.
73. Barnett GC, Wilkinson J, Moody AM, Wilson CB, Sharma R, Klager S, et al. A randomised controlled trial of forwardplanned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results. Radiother Oncol 2009; 92: 34-41.
74. Van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Hollander M, Langendijk JA. Three-Dimensional Conformal Simultaneously Integrated Boost Technique for Breast-Conserving Radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1018-1023.
75. Freedman GM, Anderson PR, Goldstein LJ, Ma C, Li J, Swaby RF, et al. Four-Week Course of Radiation for Breast Cancer Using Hypofractionated Intensity Modulated Radiation Therapy with an Incorporated Boost. Int J Radiat Oncol Biol Phys 2007; 68: 347-353.
76. McDonald MW, Godette KD, Whitaker DJ, Davis LW, Johnstone PA. Three-Year Ootcomes of Breast Intensity Modulated Radiation Therapy with Simultaneous Integrated Boost. Int J Radiat Oncol Biol Phys 2010; 77: 523-530.
77. Benda RK, Yasuda G, Sethi A, Gabram SG, Hinerman RW, Mendenhall NP. Breast boost: Are we missing the target?. Cancer 2003; 97: 905-909.
78. Vaidya JS, Baum M, Tobias JS, Wenz F, Massarut S, Keshtgar M, et al. Long-Term Results of Targeted Intraoperative radiotherapy (TARGIT) Boost During Breast-Conserving Surgery. Int J Radiat Oncol Biol Phys 2011; 81: 1091-1097.
79. Wenz F, Welzel G, Blank E, Hermann B, Steil V, Sutterlin M, et al. Intraoperative Radiotherapy as a Boost During Breast-Conserving Surgery Using Low-Kilovoltage X-Rays: The First 5 Years of Experience with a Novel Approach. Int J Radiat Oncol Biol Phys 2010; 77: 1309-1314.
80. Kraus-Tiefenbacher U, Bauer L, Scheda A, Fleckenstein K, Keller A, Herskind C, et al. Long-Term Toxicity of an Intraoperative Radiotherapy Boost Using Low Energy X-Rays During Breast-Conserving Surgery. Int J Radiat Oncol Biol Phys 2006; 66: 377-381.
81. Graham P, Capp A, Fox C, Nasser E, Delaney G, Ahem V. Why a breast boost should remain a controversial aspect of routine breast conservation management in Australia and New Zealand in 2002. Australas Radiol 2003; 47: 44-49.
82. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371: 1098-1107.
83. Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M, et al. Full-dose intra-operative radiotherapy with electrons (ELIOT) during breast-conserving surgery: experience with 1246 cases. Ecancermedicalscience 2008; 2: 65.
84. Lemanski C, Azria D, Thezenas S, Gutowski M, Saint-Aubert B, Rouanet P, et al. Intraoperative Radiotherapy Given as a Boost for Early Breast Cancer: Long-Term Clinical and Cosmetic Results. Int J Radiat Oncol Biol Phys 2006; 64: 1410-1415.
85. Ivaldi GB, Leonardi MC, Orecchia R, Zerini D, Morra A, Galimberti V, et al. Preliminary Results of Electron Intraoperative Therapy Boost and Hypofractionated External Beam Radiotherapy after Breast-Conserving Surgery in Premanopausal Women. Int J Radiat Oncol Biol Phys 2008; 72: 485-493.
86. McIntosh F, Sheng K, Read P. Evaluation of Hypofractionated Simultaneous Integrated Breast Boost using Tomotherapybased Topotherapy (abstract). Int J Radiat Oncol Biol Phys 2008; 72: 518.
87. Hijal T, Fournier-Bidoz N, Castro-Pena P, Kirova YM, Zefkili S, Bollet MA, et al. Simultaneous integrated boost in breast-conserving treatment of breast cancer: A dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy. Radiother Oncol 2010; 94: 300-306.
88. Toscas JI, Linero D, Rubio I, Hidalgo A, Arnalte R, Escudé L, et al. Boosting the tumor bed from deep-seated tumors in earlystage breast cancer: A planning study between electron, photon, and proton beams. Radiother Oncol 2010; 96: 192-198.
89. Van der Laan HP, Hurkmans CW, Kuten A, Westenberg HA. Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol 2010; 94: 280-285.
90. Probst H, Griffiths S. Moving to a high-tech approach to the irradiation of early breast cancer: Is it possible to balance efficacy, morbidity and resource use? Clin Oncol 2006; 18: 268-275.
91. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial. Lancet Oncol 2006; 7: 467-471.
92. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial. Radiother Oncol 2005; 75: 9-17.
93. Bantema-Joppe EJ, van der Laan HP, de Bock GH, Wijsman R, Dolsma WV, Busz DM, Langendijk JA, Maduro JH. Three-dimensional conformal hypofractionated simultaneous integrated boost in breast-conserving therapy: Results on local control and survival. Radiother Oncol 2011; 100: 215-220.
94. Smith BD, Bentzen SM, Correa CR, Hahn CA, Hardenbergh PH, Iibott GS, et al. Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Int J Radiat Oncol Biol Phys 2011; 81: 59-68.
95. Coles CE, Yarnold JR. The IMPORT trials are launched. Clin Oncol 2006; 18: 87-590.
96. Donovan EM, Ciurlionis L, Fairfoul J, James H, Mayles H, Manktelow S, et al. Planning with Intensity-Modulated Radiotherapy and Tomotherapy to Modulate Dose Across Breast to Reflect Recurrence Risk (IMPORT HIGH Trial). Int J Radiat Oncol Biol Phys 2011; 79: 1064-1072.
97. Nagykalnai T, Nemeskeri CS, Mayer A. Effectivity of boost radiotherapy on the local recurrence rate following breastconserving surgery plus whole breast irradiation. Eur J Cancer 1998; 34: 29-33.
98. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15: 963-968.
99. Teissier E, Henry M, Ramaioli A. Boost in conservative treatment: 6 year results of randomized trial (abstract). Breast Cancer Res Treat 1998; 50: 287.
100. Offersen BV, Overgaard M, Kroman N, Overgaard J. Accelerated partial breast irradiation as part of breastconserving therapy of early breast carcinoma: A systematic review. Radiother Oncol 2010; 90: 1-13.
101. Mansfield CM, Komarnicky LT, Schwartz GF, Rosenberg AL, Krishnan L, Jewell WR. Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 1995; 75: 2328-2336.
102. Touboul E, Belkacemi Y, Lefranc JP, Uzan S, Ozsahin M, Korbas D. Early breast cancer: Influence of type of boost (electrons vs. iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 1995; 34: 105-113.
103. Perez CA, Taylor ME, Halverson K., Garcia D., Kuske RR, Lockett MA. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: A nonrandomized comparison. Int J Radiat Oncol Biol Phys 1996; 34: 995-1007.
104. Guix B, Henriquez I, Martinez A, Lejarcegui JA, Finestres F. Low dose rate (LDR) brachytherapy (BQT) boost in preserving-breast cancer patients: The 18 year experience of Radiation Oncology Medical Institute (IMOR) of Barcelona. Int J Radiat Oncol Biol Phys 2001; 64: 1410-1415.
105. Resch A, Potter R, Van Limbergen E, Biber E, Klein T, Fellner C, et al. Long-term results (10 years) of intensive breastconserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol 2002; 63: 47-58.
106. Murphy C, Anderson PR, Li T, Bleicher RJ, Sigurdson ER, Golstein LJ, et al. Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation. Int J Radiat Oncol Biol Phys 2011; 81: 69-76.
107. Polgar C, Janvary L, Majora T, Somogyi A, Takacsi-Nagy Z, Frohlich G, Fodor J. The role of high-dose-rate brachytherapy boost in breast-conserving therapy: Long-term results of the Hungarian National Institute of Oncology. Rep Practical Oncol Radiother 2010; 15: 1-7.